Evidence map›Paper›PMID 34660586›Full record

ArticleFrontiers in cell and developmental biology2021

Human Induced Pluripotent Stem Cell-Derived TDP-43 Mutant Neurons Exhibit Consistent Functional Phenotypes Across Multiple Gene Edited Lines Despite Transcriptomic and Splicing Discrepancies.

Alec S T Smith, Changho Chun, Jennifer Hesson, Julie Mathieu, Paul N Valdmanis, David L Mack, Byung-Ok Choi, Deok-Ho Kim, Mark Bothwell

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Reversal ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Alec S T SmithDepartment of Physiology and Biophysics, University of Washington, Seattle, WA, United States.
Changho ChunDepartment of Bioengineering, University of Washington, Seattle, WA, United States.
Jennifer HessonInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States.
Julie MathieuInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States.
Paul N ValdmanisDivision of Medical Genetics, University of Washington, Seattle, WA, United States.
David L MackDepartment of Physiology and Biophysics, University of Washington, Seattle, WA, United States.
Byung-Ok ChoiDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Deok-Ho KimDepartment of Bioengineering, University of Washington, Seattle, WA, United States.
Mark BothwellDepartment of Physiology and Biophysics, University of Washington, Seattle, WA, United States.
University of Washington · USSamsung Medical Center · KRUniversity of Washington Medical Center · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI DANIEL DOHERTY · 2020 to 2026
$9.9M
NICHD NIH HHS P50 HD103524NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

Gene editing technologies hold great potential to enhance our ability to model inheritable neurodegenerative diseases. Specifically, engineering multiple amyotrophic lateral sclerosis (ALS) mutations into isogenic cell populations facilitates determination of whether different causal mutations cause pathology

Indexed as

ALS (amyotrophic lateral sclerosis)disease modelelectrophysiologic analysisiPSC (induced pluripotent stem cell)transcriptomics

Identifiers

PMID34660586
PMCPMC8511491
OpenAlexW3204532686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.